10 June 2021 - Penny Tucker is concerned that there are “miracle drugs and biologics that have transformed many conditions from a death sentence to a surmountable challenge” and blames the lack of supply of these squarely on PHARMAC. 

She is disappointed that PHARMAC’s budget is not part of the review and is critical of its bureaucracy.

I acknowledge that she has declared no involvement with the pharmaceutical industry but her arguments sound about the same as those from Graeme Jarvis of Medicines New Zealand. She makes no mention of the role that the pharmaceutical industry plays in the difficulty of funding these.

Read Stuff article